Simplex Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Simplex Trading’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3	Closed	-$5K	–	9492
2020 Q3	$5K	Sell	3 -3	-50%	-$43	﹤0.01%	7163
2020 Q2	$8K	Sell	6 -18	-75%	-$278	﹤0.01%	6790
2020 Q1	$34K	Buy	24 +8	+50%	+$131	﹤0.01%	5535
2019 Q4	$27K	Sell	16 -21	-57%	-$391	﹤0.01%	5744
2019 Q3	$56K	Sell	37 -11	-23%	-$234	﹤0.01%	4922
2019 Q2	$112K	Buy	48 +10	+26%	+$247	﹤0.01%	4070
2019 Q1	$107K	Buy	38 +25	+192%	+$728	﹤0.01%	4279
2018 Q4	$39K	Sell	13 -63	-83%	-$1.77K	﹤0.01%	4778
2018 Q3	$266K	Buy	+76	New	+$2.3K	﹤0.01%	3313

Simplex Trading's AKCA Position: Q4 2020 in Review

Simplex Trading sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 400 shares — an estimated $7K sold.

Simplex Trading first reported a position in AKCA in Q1 2019 and held it in 5 quarters. The position peaked at $37K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Simplex Trading reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Simplex Trading sold 400 Akcea Therapeutics Inc shares in Q4 2020, an estimated $7K.
Simplex Trading first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 5 quarters.
Simplex Trading's Akcea Therapeutics Inc position peaked at $37K in Q1 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.